The influence of two neurohormones on breast cancer: prolactin and melatonin
Authors:
- Cecília da Silva FerreiraCFCecília da Silva Ferreira
- Kátia Cândido CarvalhoKCKátia Cândido Carvalho
- Isaque da Silva FerreiraIFIsaque da Silva Ferreira
- Giovanna Santos CavalcantiGCGiovanna Santos Cavalcanti
- José Cipolla NetoJNJosé Cipolla Neto
- Pedro Egydio Oliveira ZambottiPZPedro Egydio Oliveira Zambotti
- Edmund Chada BaracatEBEdmund Chada Baracat
- José Maria Soares JuniorJJJosé Maria Soares Junior
Open Access
- 1 January 2025
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (11) , e20251014
Abstract
The influence of prolactin (PRL) and melatonin on breast cancer represents a complex interplay of hormonal signaling with significant implications for tumor progression and therapeutic strategies. PRL, a polypeptide hormone produced primarily by the pituitary gland but also locally in mammary tissue, plays a dual role in breast physiology and pathology1. It acts synergistically with estrogen and progesterone to promote proliferation and differentiation of mammary epithelial cells, processes that are essential for lactation1,2. However, its involvement in breast cancer remains debated, with most studies suggesting proliferative and pro-metastatic effects. PRL exerts its actions through specific transmembrane receptors (prolactin receptor [PRLR])1,2, activating signaling pathways such as JAK2/STAT5, Ras/MAPK, and PI3K/AKT, which drive cell survival, proliferation, and differentiation. Controversially, while PRL overexpression in cell culture enhances tumor growth, PRLR knockdown or antagonism can lead to more aggressive but less differentiated tumors, highlighting the context-dependent nature of PRL's role in breast cancer. Therefore, blood PRL concentration is important for the development of cancer1-4.Keywords
Funding Information
- São Paulo Research Foundation (2018/24224-9)
- São Paulo Research Foundation (88887923970/2023-00)
- Coordination for the Improvement of Higher Education Personnel (2018/24224-9)
- Coordination for the Improvement of Higher Education Personnel (88887923970/2023-00)
This publication has 40 references indexed in Scilit:
- Molecular and cellular mechanisms of melatonin in breast cancerBiochimie, 2022
- MelatoninCurrent Biology, 2021
- Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasisSeminars in Cell & Developmental Biology, 2021
- Melatonin: A Potential Therapeutic Option for Breast CancerTrends in Endocrinology & Metabolism, 2020
- Melatonin and its ubiquitous anticancer effectsMolecular and Cellular Biochemistry, 2019
- Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancerCancer Letters, 2015
- Regulation of Blood Vessels by Prolactin and Vasoinhibins2014
- A Positive Feedback Loop Between Prolactin and Stat5 Promotes Angiogenesis2014
- Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma modelActa Histochemica, 2014
- The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitroToxicology in Vitro, 2014